These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients. Giancane G, Lavarello C, Pistorio A, Oliveira SK, Zulian F, Cuttica R, Fischbach M, Magnusson B, Pastore S, Marini R, Martino S, Pagnier A, Soler C, Staņēvicha V, Ten Cate R, Uziel Y, Vojinovic J, Fueri E, Ravelli A, Martini A, Ruperto N, Paediatric Rheumatology International Trials Organisation (PRINTO). Pediatr Rheumatol Online J; 2019 May 22; 17(1):24. PubMed ID: 31118099 [Abstract] [Full Text] [Related]
7. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial. Ruperto N, Pistorio A, Oliveira S, Zulian F, Cuttica R, Ravelli A, Fischbach M, Magnusson B, Sterba G, Avcin T, Brochard K, Corona F, Dressler F, Gerloni V, Apaz MT, Bracaglia C, Cespedes-Cruz A, Cimaz R, Couillault G, Joos R, Quartier P, Russo R, Tardieu M, Wulffraat N, Bica B, Dolezalova P, Ferriani V, Flato B, Bernard-Medina AG, Herlin T, Trachana M, Meini A, Allain-Launay E, Pilkington C, Vargova V, Wouters C, Angioloni S, Martini A, Paediatric Rheumatology International Trials Organisation (PRINTO). Lancet; 2016 Feb 13; 387(10019):671-678. PubMed ID: 26645190 [Abstract] [Full Text] [Related]
8. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. Reiff A, Rawlings DJ, Shaham B, Franke E, Richardson L, Szer IS, Bernstein BH. J Rheumatol; 1997 Dec 13; 24(12):2436-43. PubMed ID: 9415655 [Abstract] [Full Text] [Related]
9. Chlorambucil. An effective corticosteroid-sparing agent for patients with recalcitrant dermatomyositis. Sinoway PA, Callen JP. Arthritis Rheum; 1993 Mar 13; 36(3):319-24. PubMed ID: 8452575 [Abstract] [Full Text] [Related]